2,3,5,6-Tetrachloropyridine → HCID 58484700, compound
Reaction equation
[CH2:1]([O:3][CH2:4][C@@H:5]1[CH2:9][O:8][C:7](=[O:10])[N:6]1[C:11]1[CH:16]=[CH:15][C:14]([C:17]([N:19]2[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]2)=[O:18])=[CH:13][CH:12]=1)[CH3:2].[Cl:25][C:26]1[C:31]([Cl:32])=[CH:30][C:29]([Cl:33])=[C:28](Cl)[N:27]=1>>[CH2:1]([O:3][CH2:4][C@@H:5]1[CH2:9][O:8][C:7](=[O:10])[N:6]1[C:11]1[CH:16]=[CH:15][C:14]([C:17]([N:19]2[CH2:20][CH2:21][N:22]([C:28]3[C:29]([Cl:33])=[CH:30][C:31]([Cl:32])=[C:26]([Cl:25])[N:27]=3)[CH2:23][CH2:24]2)=[O:18])=[CH:13][CH:12]=1)[CH3:2]Participants
3
Procedure
By reaction and treatment in the same manner as in Example 147 and using (R)-4-ethoxymethyl-3-[4-(piperazine-1-carbonyl)phenyl]oxazolidin-2-one (500 mg) described in Preparation Example 167 and 2,3,5,6-tetrachloropyridine (488 mg), the title compound (651 mg) was obtained.
Workup
- customBy reaction and treatment in the same manner as in Example 147
Sources & evidence
- ORD record
- ord-61f3b2ae8b114e0bbb40edd44d6f74df
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…